1. Home
  2. PZG vs CRBU Comparison

PZG vs CRBU Comparison

Compare PZG & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paramount Gold Nevada Corp.

PZG

Paramount Gold Nevada Corp.

HOLD

Current Price

$1.45

Market Cap

132.1M

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.61

Market Cap

145.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PZG
CRBU
Founded
1992
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Mining
Medicinal Chemicals and Botanical Products
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.1M
145.8M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
PZG
CRBU
Price
$1.45
$1.61
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$10.75
AVG Volume (30 Days)
494.7K
1.0M
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.64
EPS
N/A
N/A
Revenue
$330,259.00
N/A
Revenue This Year
N/A
$1.63
Revenue Next Year
N/A
$10.93
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.82
$1.38
52 Week High
$2.70
$3.53

Technical Indicators

Market Signals
Indicator
PZG
CRBU
Relative Strength Index (RSI) 59.51 41.81
Support Level $1.07 $1.40
Resistance Level $1.46 $1.65
Average True Range (ATR) 0.09 0.07
MACD 0.02 0.01
Stochastic Oscillator 58.74 45.76

Price Performance

Historical Comparison
PZG
CRBU

About PZG Paramount Gold Nevada Corp.

Paramount Gold Nevada Corp is an exploration-stage mining company. Together with its subsidiaries, the company is engaged in the business of acquiring, exploring, and developing precious metal projects in the United States. Also, it explores for gold and silver. The company enhances the value of projects by implementing exploration and engineering programs that are likely to expand and upgrade known mineralized material to reserves. Its projects include sleeper gold, grassy mountain gold, frost project, other non-material, and others.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: